Bio-Connect

Tenascin C (TNC)

Research Use Only
TEN001
Nordic-MUbio
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetTNC
Price on request
1 ml
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Nordic-MUbio
  • Product Name
    Tenascin C (TNC)
  • Delivery Days Customer
    7
  • Application Supplier Note
    IHC(C,P), WB
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    Immunohistochemistry (frozen);Immunohistochemistry (paraffin);Western Blotting;Immunohistochemistry (frozen);Immunohistochemistry (paraffin)
  • Category Supplier
    Primary Antibodies
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    T2H5
  • Concentration
    50 ug/ml
  • Gene ID3371
  • Target name
    TNC
  • Target description
    tenascin C
  • Target synonyms
    150-225; cytotactin; deafness, autosomal dominant 56; DFNA56; glioma-associated-extracellular matrix antigen; GMEM; GP; GP 150-225; hexabrachion (tenascin); HXB; JI; myotendinous antigen; neuronectin; tenascin; tenascin-C additional domain 1; TN; TN-C
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP24821
  • Protein Name
    Tenascin
  • Reactivity
    Human
  • Reactivity Supplier Note
    Purified Tenascin derived from mammary tumour cells
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • 1. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion. Br J Dermatol. 1997 Aug;137(2):171-8. 2. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol. 1996 Apr;148(4):1219-28. 3. Rulo HF, van Vlijmen-Willems IM, Schalkwijk J, Verstraeten AA, van de Kerkhof PC. Normal human skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal proliferation (Ki-67 binding).J Dermatol Sci. 1993 Feb;5(1):54-7. 4. Verstraeten AA, Mackie EJ, Hageman PC, Hilgers J, Schol DJ, De Jongh GJ, Schalkwijk J. Tenascin expression in basal cell carcinoma. Br J Dermatol. 1992 Dec;127(6):571-4. 5. Müller S., Neureiter D., Stolte M. et al. (1991) Virchows Arch. 438; 435-441.